Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 3

Immune checkpoint inhibitors - PD-1 and PD-L1- induce higher response rate across worst cancer tumours such as lung cancer

The lining of the lung (brown), cancerous cells (purple), and mucus (grey) as shown by coloured scanning electron microscope. Clinical trials of the new treatments that targets a patient's immune system are improving survival rates to previously intractable cancers, including melanoma and lung cancer

Source  Eye of Science / Science Photo Library